Condition: Asthma
Interventions: Drug: QAW039; Drug: QAW039; Drug: Placebo
Sponsor: Novartis Pharmaceuticals
Not yet recruiting – verified July 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Study to Evaluate Efficacy & Safety of Tralokinumab in Subjects With Asthma Inadequately Controlled on Corticosteroids (ICS) With or Without Other Controllers
Condition: Asthma
Interventions: Biological: Tralokinumab; Other: Placebo
Sponsor: AstraZeneca
Not yet recruiting – verified May 2015
View full post on ClinicalTrials.gov: asthma | received in the last 14 days
Omalizumab effective in treating inadequately controlled allergic asthma – HealthCanal.com
|
Omalizumab effective in treating inadequately controlled allergic asthma
HealthCanal.com HOUSTON — Patients with severe allergic asthma that is inadequately controlled with the standard of care had improved symptoms and decreased flare-ups with injections of an antibody drug called omalizumab, according to experts at Baylor College of … |
View full post on asthma – Google News
Omalizumab effective in treating inadequately controlled allergic asthma – BCM News
|
Omalizumab effective in treating inadequately controlled allergic asthma
BCM News HOUSTON — (May 5, 2011) — Patients with severe allergic asthma that is inadequately controlled with the standard of care had improved symptoms and decreased flare-ups with injections of an antibody drug called omalizumab, according to experts at … Adding Omalizumab May Improve Uncontrolled Asthma |
View full post on asthma – Google News
AMG 853 Phase 2 Study in Subjects With Inadequately Controlled Asthma
Condition: Asthma
Interventions: Drug: AMG 853; Drug: AMG 853; Drug: AMG 853; Drug: AMG 853; Drug: Placebo
Sponsor: Amgen
Active, not recruiting – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
A Randomized, Double-blind Study to Evaluate the Dosing of AMG 827 for Subjects With Inadequately Controlled Asthma
Condition: Asthma
Interventions: Drug: AMG 827; Drug: AMG 827; Drug: AMG 827; Drug: Placebo
Sponsor: Amgen
Not yet recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days